Superior antibody immunogenicity of a RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults
Sarah E. Silk, Wilmina F. Kalinga, Ivanny M. Mtaka, Nasoro S. Lilolime, Maximillian Mpina, Florence Milando, Saumu Ahmed, Ababacar Diouf, Fatuma Mkwepu, Beatus Simon, Thabit Athumani, Mohammed Rashid, Latipha Mohammed, Omary Lweno, Ali M. Ali, Gloria Nyaulingo, Bakari Mwalimu, Sarah Mswata, Tunu G. Mwamlima, Jordan R. Barrett, Lawrence T. Wang, Yrene Themistocleous, Lloyd D. W. King, Susanne H. Hodgson, Ruth O. Payne, Carolyn M. Nielsen, Alison M. Lawrie, Fay L. Nugent, Jee-Sun Cho, Carole A. Long, Kazutoyo Miura, View ORCID ProfileSimon J. Draper, View ORCID ProfileAngela M. Minassian, Ally I. Olotu
doi: https://doi.org/10.1101/2023.04.17.23288686
Sarah E. Silk
1Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, OX1 3QU, UK
2Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford, OX3 7LE, UK
3Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, Oxford, OX1 3QU, UK
Wilmina F. Kalinga
4Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania
Ivanny M. Mtaka
4Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania
Nasoro S. Lilolime
4Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania
Maximillian Mpina
4Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania
Florence Milando
4Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania
Saumu Ahmed
4Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania
Ababacar Diouf
5Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, MD 20852, USA
Fatuma Mkwepu
4Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania
Beatus Simon
4Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania
Thabit Athumani
4Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania
Mohammed Rashid
4Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania
Latipha Mohammed
4Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania
Omary Lweno
4Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania
Ali M. Ali
4Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania
Gloria Nyaulingo
4Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania
Bakari Mwalimu
4Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania
Sarah Mswata
4Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania
Tunu G. Mwamlima
4Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania
Jordan R. Barrett
1Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, OX1 3QU, UK
2Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford, OX3 7LE, UK
3Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, Oxford, OX1 3QU, UK
Lawrence T. Wang
1Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, OX1 3QU, UK
3Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, Oxford, OX1 3QU, UK
Yrene Themistocleous
2Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford, OX3 7LE, UK
Lloyd D. W. King
1Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, OX1 3QU, UK
2Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford, OX3 7LE, UK
3Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, Oxford, OX1 3QU, UK
Susanne H. Hodgson
1Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, OX1 3QU, UK
2Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford, OX3 7LE, UK
3Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, Oxford, OX1 3QU, UK
Ruth O. Payne
2Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford, OX3 7LE, UK
Carolyn M. Nielsen
1Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, OX1 3QU, UK
2Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford, OX3 7LE, UK
3Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, Oxford, OX1 3QU, UK
Alison M. Lawrie
2Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford, OX3 7LE, UK
Fay L. Nugent
1Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, OX1 3QU, UK
2Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford, OX3 7LE, UK
Jee-Sun Cho
1Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, OX1 3QU, UK
2Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford, OX3 7LE, UK
3Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, Oxford, OX1 3QU, UK
Carole A. Long
5Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, MD 20852, USA
Kazutoyo Miura
5Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, MD 20852, USA
Simon J. Draper
1Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, OX1 3QU, UK
2Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford, OX3 7LE, UK
3Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, Oxford, OX1 3QU, UK
Angela M. Minassian
1Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, OX1 3QU, UK
2Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford, OX3 7LE, UK
3Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, Oxford, OX1 3QU, UK
Ally I. Olotu
4Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania
Article Information
History
- April 20, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Sarah E. Silk1,2,3,
- Wilmina F. Kalinga4,
- Ivanny M. Mtaka4,
- Nasoro S. Lilolime4,
- Maximillian Mpina4,
- Florence Milando4,
- Saumu Ahmed4,
- Ababacar Diouf5,
- Fatuma Mkwepu4,
- Beatus Simon4,
- Thabit Athumani4,
- Mohammed Rashid4,
- Latipha Mohammed4,
- Omary Lweno4,
- Ali M. Ali4,
- Gloria Nyaulingo4,
- Bakari Mwalimu4,
- Sarah Mswata4,
- Tunu G. Mwamlima4,
- Jordan R. Barrett1,2,3,
- Lawrence T. Wang1,3,
- Yrene Themistocleous2,
- Lloyd D. W. King1,2,3,
- Susanne H. Hodgson1,2,3,
- Ruth O. Payne2,
- Carolyn M. Nielsen1,2,3,
- Alison M. Lawrie2,
- Fay L. Nugent1,2,
- Jee-Sun Cho1,2,3,
- Carole A. Long5,
- Kazutoyo Miura5,
- Simon J. Draper1,2,3,*,
- Angela M. Minassian1,2,3,*,† and
- Ally I. Olotu4,*
- 1Department of Biochemistry, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, OX1 3QU, UK
- 2Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, University of Oxford, Old Road Campus, Oxford, OX3 7LE, UK
- 3Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, Oxford, OX1 3QU, UK
- 4Interventions and Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania
- 5Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, MD 20852, USA
- ↵†Corresponding author: Dr Angela M. Minassian; angela.minassian{at}bioch.ox.ac.uk
↵* These authors contributed equally.
Posted April 20, 2023.
Superior antibody immunogenicity of a RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults
Sarah E. Silk, Wilmina F. Kalinga, Ivanny M. Mtaka, Nasoro S. Lilolime, Maximillian Mpina, Florence Milando, Saumu Ahmed, Ababacar Diouf, Fatuma Mkwepu, Beatus Simon, Thabit Athumani, Mohammed Rashid, Latipha Mohammed, Omary Lweno, Ali M. Ali, Gloria Nyaulingo, Bakari Mwalimu, Sarah Mswata, Tunu G. Mwamlima, Jordan R. Barrett, Lawrence T. Wang, Yrene Themistocleous, Lloyd D. W. King, Susanne H. Hodgson, Ruth O. Payne, Carolyn M. Nielsen, Alison M. Lawrie, Fay L. Nugent, Jee-Sun Cho, Carole A. Long, Kazutoyo Miura, Simon J. Draper, Angela M. Minassian, Ally I. Olotu
medRxiv 2023.04.17.23288686; doi: https://doi.org/10.1101/2023.04.17.23288686
Superior antibody immunogenicity of a RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults
Sarah E. Silk, Wilmina F. Kalinga, Ivanny M. Mtaka, Nasoro S. Lilolime, Maximillian Mpina, Florence Milando, Saumu Ahmed, Ababacar Diouf, Fatuma Mkwepu, Beatus Simon, Thabit Athumani, Mohammed Rashid, Latipha Mohammed, Omary Lweno, Ali M. Ali, Gloria Nyaulingo, Bakari Mwalimu, Sarah Mswata, Tunu G. Mwamlima, Jordan R. Barrett, Lawrence T. Wang, Yrene Themistocleous, Lloyd D. W. King, Susanne H. Hodgson, Ruth O. Payne, Carolyn M. Nielsen, Alison M. Lawrie, Fay L. Nugent, Jee-Sun Cho, Carole A. Long, Kazutoyo Miura, Simon J. Draper, Angela M. Minassian, Ally I. Olotu
medRxiv 2023.04.17.23288686; doi: https://doi.org/10.1101/2023.04.17.23288686
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2877)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12603)
- Forensic Medicine (10)
- Gastroenterology (811)
- Genetic and Genomic Medicine (4476)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2867)
- Health Policy (1057)
- Hematology (378)
- HIV/AIDS (907)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4233)
- Nursing (226)
- Nutrition (619)
- Oncology (2218)
- Ophthalmology (630)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (485)
- Public and Global Health (6818)
- Radiology and Imaging (1502)
- Respiratory Medicine (907)
- Rheumatology (430)
- Sports Medicine (373)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)